BioMed Research International / 2015 / Article / Fig 1

Research Article

S100B Inhibitor Pentamidine Attenuates Reactive Gliosis and Reduces Neuronal Loss in a Mouse Model of Alzheimer’s Disease

Figure 1

(a) Western blot and (b–f) densitometric analysis (arbitrary units normalized on the expression of the housekeeping protein -actin) showing the effect of 7 days of intrahippocampal injection of pentamidine (0.05–5 g/mL/day) on GFAP (b), iNOS (c), p-p38 MAPK (d), COX-2 (e), and RAGE (f) expression in A-injected mice. Results are expressed as mean ± SEM of experiments performed in triplicate. versus vehicle-treated mice; , and versus A-treated mice.
(a)
(b)
(c)
(d)
(e)
(f)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.